Isis Pharmaceuticals Inc. of Carlsbad, Calif., promoted DanielKisner to chief operating officer from executive vice presidentand Christopher Mirabelli to executive vice president ofresearch and preclinical development from senior vicepresident. Isis also promoted B. Lynne Parshall to senior vicepresident and general counsel. She retains her title as secretaryof Isis' board of directors.
Neurocrine Biosciences Inc. of San Diego, named Gary Lyonspresident and chief executive officer. Lyons was vice presidentof business development at Genentech Inc.
ImmunoGen Inc. of Cambridge, Mass., named Robert Tellis vicepresident of corporate development. Tellis was vice presidentof corporate planning at Ciba-Corning Diagnostics.
Centocor Inc. of Malvern, Pa., named Stephen Hayter anexecutive vice president and head of Centocor DiagnosticsDivision. Hayter was an executive vice president at CambridgeBiotech Corp. and general manager of its diagnostics division.
Cor Therapeutics Inc. of South San Francisco, Calif. namedMichael Kitt vice president of clinical research. Kitt was thesenior vice president of clinical research at Sterling WinthropInc.'s pharmaceutical research and development division.
Advanced Polymer Systems Inc. of Redwood City, Calif., electedto its board of directors Dennis Winger, senior vice president,finance and administration and chief financial officer at ChironCorp.
(c) 1997 American Health Consultants. All rights reserved.